Introducing innovative molecular genetics technologies into healthcare practice “Lytech” makes them affordable for the majority of practicing physicians. The main directions of the company are:

research in the field of molecular diagnostics;
modern equipment and expendables for diagnostic and scientific laboratories;
production of test-systems (reagents) for PCR and ELISA diagnostics;
development and production reagents for determination of polymorphisms (SNP) in the human genome;
development and production of PCR reagent kits for veterinary diagnostics;

Rich scientific and research database ensures leadership of “Lytech” Company in the field of development and modernization of unique test-systems for laboratory diagnostics.
Over 25 years “Lytech” Company has been engaged in development and successful realization of sets for diagnostics of various infectious diseases both of bacterial and viral origin.

Our sets of reagents can be used for any detection scheme (real-time, end-point, electrophoresis). Our innovative developments are characterized by simplicity of usage, profitable price-quality-ratio and universality:

Kits for isolation of DNA and RNA from samples;
PCR kits for diagnostics of urogenital infections;
Complex program for diagnostics of reproductive function disturbances in males «Men’s health»;
Complex program for making a diagnosis of bacterial vaginosis;
PCR kits for revealing resistance of microorganisms to antibiotics;
Molecular genetic test for diagnostics of periodontal pathogens;
Unique PCR test-systems for determination of polymorphisms in the human genome (over 200 mutations);
Some profiles for the diagnosis of mutations associated with multifactorial diseases (for example, trombophilia);
The hereditary diseases diagnostic kits;
Our diagnostic kits were adapted by the most devices.